Dyslipidemias
📧 Sign up to get email alerts when something new happens for Dyslipidemias.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-24Clinical Trial Update: Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients [Phase 4]
Phase 4 trial assessing efficacy and safety of bempedoic acid combined with anti-PCSK9 therapy and ezetimibe in statin-intolerant patients.
-
CLINICAL_TRIALS trial_result · 2024-02-16Clinical Trial Update: Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins [Phase 4]
Phase 4 trial evaluating the efficacy, safety, and cost-efficacy of a pre-emptive genotyping strategy in patients receiving statins.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities [Phase 4]
Phase 4 trial evaluating safety and effectiveness of saroglitazar 4 mg in patients with NAFLD and comorbidities.
-
CLINICAL_TRIALS trial_result · 2024-01-22Clinical Trial Update: Communicating Health Information and Improving Coordination With Primary Care [NA]
Clinical trial update related to communicating health information and improving coordination with primary care; study completed with posted …
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia [Phase 3]
Phase 3 trial update for a fixed-dose combination of atorvastatin and perindopril in adults with arterial hypertension and dyslipidemia; stu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular Disease [Phase 4]
Phase 4 trial update on the lipid-lowering efficacy of an extended-release niacin/laropiprant combination in cardiovascular disease; the stu…
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Efficacy Assessment of Chinese Herbal Medicine Jiangtang Tiaozhi Recipe Treating Participants With Glucose and Lipid Metabolism Disturbances [Phase 1, Phase 2]
Phase 1/2 clinical trial assessing the efficacy of Jiangtang Tiaozhi Recipe, a Chinese herbal medicine, for glucose and lipid metabolism dis…
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: A Multicenter Study to Evaluate the Effect of High Dose Rosuvastatin Versus Rosuvastatin and Ezetimibe in Stroke [Phase 4]
A Phase 4 multicenter clinical trial comparing high-dose rosuvastatin to rosuvastatin with ezetimibe in patients with dyslipidemias and acut…
-
CLINICAL_TRIALS research · 2022-12-22Clinical Trial Update: Effect of Low Carbohydrate Versus Low Fat Diet in the Treatment of Dyslipidemia in Obese Children With Metabolic Syndrome [NA]
A completed clinical trial comparing low carbohydrate versus low fat diets for dyslipidemia in obese children with metabolic syndrome; resul…
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: A Dose-response Study of Dietary Resveratrol on Lipid Metabolism Disorder [Phase 3]
Phase 3 trial assessing dose-response effects of dietary resveratrol on lipid metabolism disorders completed.
-
CLINICAL_TRIALS trial_result · 2022-10-13Clinical Trial Update: The Safety and Long-Term Clinical Benefit of PCSK9i in STEMI Patients [Phase 4]
A Phase 4 trial update assessing the safety and long-term clinical benefit of a PCSK9 inhibitor in patients with ST-elevation myocardial inf…
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia [Phase 4]
Phase 4 trial comparing rosuvastatin/amlodipine vs atorvastatin/amlodipine in patients with dyslipidemia and hypertension; study completed.
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70) [Phase 2]
A Phase 2 dose-ranging study of vupanorsen (TRANSLATE-TIMI 70) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-07-15Clinical Trial Update: Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients [Phase 2]
Phase 2 dose-ranging study evaluating intravenous atorvastatin in hypercholesterolemia; results have been posted after completion.
-
CLINICAL_TRIALS trial_result · 2022-06-08Clinical Trial Update: Efprezimod Alfa (CD24Fc, MK-7110) Administration to Decrease Low-Density Lipoprotein (LDL) and Inflammation in Human Immunodeficiency Virus (HIV) Patients (CALIBER) (MK-7110-003) [Phase 2]
Phase 2 study evaluating Efprezimod Alfa (CD24Fc, MK-7110) to reduce LDL and inflammation in HIV patients; study terminated with posted resu…
-
FDA label_change · 2022-05-27FDA Approved: FENOFIBRATE — Supplemental Application (Cipla USA Inc.)
FDA notice of a supplemental application for fenofibrate submitted by Cipla USA Inc., likely to update labeling or usage indications.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS) [Phase 2]
Phase 2 trial investigating chloroquine for metabolic syndrome conditions has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia [Phase 4]
Phase 4 clinical trial assessing the effect of virgin coconut oil on cardiometabolic parameters in patients with dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: Evaluation of Common Bean Baked Snack Consumption on Blood Lipids in Overweight People With Altered Blood Lipid Levels [Phase 2]
Phase 2 clinical trial evaluating common bean baked snack consumption on blood lipid levels in overweight individuals with dyslipidemia; stu…
-
CLINICAL_TRIALS trial_result · 2021-11-11Clinical Trial Update: Vascepa to Accelerate Lipoprotein Uptake and Elimination [Phase 1]
Phase 1 trial update on Vascepa accelerating lipoprotein uptake and elimination; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-09Clinical Trial Update: Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease [Phase 4]
Phase IV trial evaluating statin monotherapy or statin/ezetimibe with respect to hepatic steatosis in patients with hyperlipidemia and nonal…
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS) [NA]
Clinical trial on chloroquine for reducing atheroma in patients with metabolic syndrome has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia [Phase 1]
Phase 1 study evaluating LY3202328 in overweight healthy participants with dyslipidemia has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506. [Phase 3]
Phase 3 trial evaluating YYC506 for dyslipidemias is in progress, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH. [Phase 3]
Phase 3 clinical trial evaluating berberine in combination with antiretroviral therapy for metabolic syndrome in people living with HIV; cur…